论文信息 - Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial. - 字舞流文

Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial.

J. Baselga | R. Heist | G. Shapiro | N. Rizvi | J. Bendell | H. Burris | J. Infante | L. Vincent | L. Gandhi | K. Hsu | G. Locatelli | O. Richter | E. Asatiani | J. Ogden | Scott B Yerganian